Which psychiatric syndrome is correctly matched to its first-line drug of choice?

Obsessive-Compulsive Disorder (OCD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs), and fluvoxamine is one of the SSRIs that has been specifically studied and approved for this condition. The mechanism of action for fluvoxamine involves increasing the levels of serotonin in the brain, which helps to alleviate the symptoms of anxiety and obsessive thoughts that characterize OCD.

This makes fluvoxamine a first-line treatment for OCD, as numerous clinical guidelines recommend SSRIs as the most effective pharmacological intervention for this psychiatric disorder. The efficacy of fluvoxamine in reducing obsessive thoughts and compulsive behaviors is well-documented, making it the appropriate choice among the options provided.

Other options include drugs that are either not first-line treatments for their respective conditions or are used in specific situations rather than being broadly recognized as first-line therapies. For instance, phenelzine is a monoamine oxidase inhibitor that is not used as a first-line treatment for social anxiety disorder due to the dietary restrictions it imposes and potential side effects. Similarly, while alprazolam may be prescribed for panic disorder, it is typically not considered a first-line option because of the risk of dependence and its short-acting nature. Trazod